ApprovalTrail

Drug · DIN 00405612

LEVATE

Authorized, but not sold for a year or more

Authorized, but the company reports it has not been sold in Canada for at least 12 months.

Status Dormant since August 4, 2017; first marketed December 31, 1979.
Drug Identification Number (DIN)
00405612
Company (DIN owner)
Biomed PharmaMontreal, Quebec, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Amitriptyline N06AA09
Class
Human
Record last updated
June 23, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
AMITRIPTYLINE HYDROCHLORIDE75 MG

Other DINs named LEVATE